Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. 3801-06-7
2. Eflone
3. Oxylone Acetate
4. Flarex
5. Fluorometholone 17-acetate
6. Nsc 47438
7. Nsc-47438
8. 9-fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 17-acetate
9. 9i50c3i3ok
10. Chebi:78354
11. U-17323
12. Fluorometholone Acetate [usan:usp]
13. U-17,323
14. [(6s,8s,9r,10s,11s,13s,14s,17r)-17-acetyl-9-fluoro-11-hydroxy-6,10,13-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] Acetate
15. 6alpha-methyl-9alpha-fluoro-17-acetoxy-21-deoxyprednisolone
16. Ai3-52814
17. Nsc47438
18. Flarex (tn)
19. Fluorometholone-acetate
20. Unii-9i50c3i3ok
21. Schembl43184
22. U 17323
23. Fluorometholone Acetate (usp)
24. Fluorometholone Acetate [usan]
25. Chembl1201064
26. Dtxsid20191424
27. Hy-b1471
28. Zinc4213357
29. Einecs 223-270-3
30. Mfcd00866062
31. S4228
32. Akos025401542
33. Ac-2172
34. Ccg-268873
35. Fluorometholone Acetate [mart.]
36. Fluorometholone Acetate [vandf]
37. Fluorometholone Acetate [usp-rs]
38. Fluorometholone Acetate [who-dd]
39. Fluorometholone 17-acetate [mi]
40. Ncgc00373228-02
41. Bs-16978
42. Nci60_004118
43. Cs-0013170
44. Fluorometholone Acetate [orange Book]
45. Sw219098-1
46. D04221
47. D81740
48. Fluorometholone Acetate [usp Monograph]
49. Ab00641960_02
50. 801f067
51. Fluorometholone Acetate 100 Microg/ml In Methanol
52. Tobrasone Component Fluorometholone Acetate
53. U 17,323
54. Fluorometholone Acetate 100 Microg/ml In Acetonitrile
55. Fluorometholone Acetate Component Of Tobrasone
56. Q27105082
57. Progesterone,17-dihydroxy-6.alpha.-methyl-,17-acetate
58. (6alpha,11beta)-17-(acetyloxy)-9-fluoro-11-hydroxy-6-methylpregna-1,4-diene-3,20-dione
59. (6alpha,11beta)-9-fluoro-11-hydroxy-6-methyl-3,20-dioxopregna-1,4-dien-17-yl Acetate
60. 17-(acetyloxy)-9-fluoro-11beta-hydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
61. 9-fluoro-11beta-hydroxy-6alpha-methyl-3,20-dioxopregna-1,4-dien-17-yl Acetate
62. Pregna-1,20-dione, 17-(acetyloxy)-9-fluoro-11-hydroxy-6-methyl-, (6.alpha.,11.beta.)-
63. Pregna-1,20-dione, 9-fluoro-11.beta.,17-dihydroxy-6.alpha.-methyl-, 17-acetate
64. (1r,2s,8s,10s,11s,14r,15s,17s)-14-acetyl-1-fluoro-17-hydroxy-2,8,15-trimethyl-5-oxotetracyclo[8.7.0.0?,?.0??,??]heptadeca-3,6-dien-14-yl Acetate
65. 9-fluoro-11.beta.,17-dihydroxy-6.alpha.-methylpregna-1,4-diene-3,20-dione 17-acetate
66. Pregna-1,4-diene-3,20-dione, 17-(acetyloxy)-9-fluoro-11-hydroxy-6-methyl-, (6.alpha.,11.beta.)-
67. Pregna-1,4-diene-3,20-dione, 17-(acetyloxy)-9-fluoro-11-hydroxy-6-methyl-, (6alpha,11beta)-
Molecular Weight | 418.5 g/mol |
---|---|
Molecular Formula | C24H31FO5 |
XLogP3 | 2.6 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 3 |
Exact Mass | 418.21555225 g/mol |
Monoisotopic Mass | 418.21555225 g/mol |
Topological Polar Surface Area | 80.7 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 892 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Flarex |
Active Ingredient | Fluorometholone acetate |
Dosage Form | Suspension/drops |
Route | Ophthalmic |
Strength | 0.1% |
Market Status | Prescription |
Company | Alcon |
2 of 2 | |
---|---|
Drug Name | Flarex |
Active Ingredient | Fluorometholone acetate |
Dosage Form | Suspension/drops |
Route | Ophthalmic |
Strength | 0.1% |
Market Status | Prescription |
Company | Alcon |
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Fluorometholone Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fluorometholone Acetate, including repackagers and relabelers. The FDA regulates Fluorometholone Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fluorometholone Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fluorometholone Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fluorometholone Acetate supplier is an individual or a company that provides Fluorometholone Acetate active pharmaceutical ingredient (API) or Fluorometholone Acetate finished formulations upon request. The Fluorometholone Acetate suppliers may include Fluorometholone Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Fluorometholone Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fluorometholone Acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Fluorometholone Acetate active pharmaceutical ingredient (API) in detail. Different forms of Fluorometholone Acetate DMFs exist exist since differing nations have different regulations, such as Fluorometholone Acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fluorometholone Acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Fluorometholone Acetate USDMF includes data on Fluorometholone Acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fluorometholone Acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fluorometholone Acetate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fluorometholone Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fluorometholone Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fluorometholone Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fluorometholone Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fluorometholone Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fluorometholone Acetate suppliers with NDC on PharmaCompass.
Fluorometholone Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fluorometholone Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fluorometholone Acetate GMP manufacturer or Fluorometholone Acetate GMP API supplier for your needs.
A Fluorometholone Acetate CoA (Certificate of Analysis) is a formal document that attests to Fluorometholone Acetate's compliance with Fluorometholone Acetate specifications and serves as a tool for batch-level quality control.
Fluorometholone Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Fluorometholone Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fluorometholone Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Fluorometholone Acetate EP), Fluorometholone Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fluorometholone Acetate USP).
LOOKING FOR A SUPPLIER?